Investors in Integral Diagnostics (ASX:IDX) Have Unfortunately Lost 40% Over the Last Three Years

Yahoo FinanceApr 24 11:45

How AI Could Boost This ASX 300 Healthcare Stock

ASX 300 healthcare stock Integral Diagnostics Ltd (ASX: IDX) is up 1.43% to $2.49 per share on Thursday.

The Motley FoolApr 18 12:28

While Institutions Own 40% of Integral Diagnostics Limited (ASX:IDX), Retail Investors Are Its Largest Shareholders With 44% Ownership

Yahoo FinanceApr 4 04:18

Capital Allocation Trends At Integral Diagnostics (ASX:IDX) Aren't Ideal

Yahoo FinanceMar 14 12:11

Morgan Stanley Adjusts Integral Diagnostics' Price Target to AU$1.85 From AU$1.70, Keeps at Underweight

09:05 PM EST, 03/05/2024 (MT Newswires) -- Morgan Stanley Adjusts Integral Diagnostics' Price Target to AU$1.85 From AU$1.70, Keeps at Underweight Price (AUD): $2.23, Change: $-0.06, Percent Change:

MT NewswiresMar 6 10:05

Integral Diagnostics Price Target Raised 13% to A$2.20/Share by Citi

Integral Diagnostics Price Target Raised 13% to A$2.20/Share by Citi

Dow JonesFeb 22 06:33